Arbutus Biopharma and Genevant Sciences are broadening the scope of their patent infringement claims against Moderna with ...

One company that played a vital role in this, by providing the LNP delivery system for Comirnaty, was Acuitas Therapeutics. The biotech, which is based in Vancouver, Canada, works with partners to ...

1. Characterization of lipid components in lipid nanoparticle (LNP) formulations – Application Note AN001928 – ...

Intellia Therapeutics reported better-than-expected results for the fourth quarter thanks to a boost in its collaboration ...

Professor Won Jong Kim stated, "Existing LNP-based delivery systems have a short expression period, limiting their use for therapeutic applications. However, the polymeric delivery system ...

The recent success of the mRNA-LNP vaccines fueled biopharma to explore lipid-based nanoparticles for advanced drug delivery. The industry is now poised to exploit the full therapeutic potential ...

The mRNA molecule is too large to pass through a cell membrane by free diffusion and carries multiple negative charges, increasing the difficulty of their delivery. The LNP nanoparticle is one of ...

BASEL, Switzerland and VANCOUVER, British Columbia and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic ...